Our team

Our team

We believe it is our full-engagement with every step of the process that makes HETERO such a strong business partner. Our unique vertical integration approach means we can offer clients a competitive and complete solution, whatever their business needs.


HETERO has first-class facilities for manufacturing a wide range of finished dosage forms. As a leading, innovation-driven corporation, our growing portfolio of pharmaceutical products meets some of the world's most urgent medical needs. Today, our global product portfolio includes 200 products in major therapeutic areas, namely:

  • Cardiovascular Disease
  • Central Nervous System
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Infectious Diseases Including HIV/AIDS
  • Oncology
  • Pain Management

From this portfolio, HETERO EUROPE will offer more than 50 products to our European partners, and we expect to add a significant number of new products each year.

Through our four finished dosage manufacturing facilities and dedicated oncology facility we offer a range of products including sterile dosage forms, pre-filled syringes, solid and liquid oral dosage forms, ointments, soft gelatine capsules and inhalers. 


Our experienced European and Indian teams work in close collaboration in order to develop eCTD dossiers of the highest quality, ensuring easy and smooth submissions across Europe by HETERO or its partners. Our European team based in Barcelona submits applications for registration and assists our partners with European submissions, through national, multiple recognition, or decentralised procedures. Our aim is to develop, compile and submit more than 20 dossiers annually, leveraging HETERO's vast portfolio from other markets across the globe.